3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Unknown
2
Sponsor Class
INDUSTRY
217
OTHER
188
NIH
12
NETWORK
11
OTHER_GOV
5
UNKNOWN
2
Study Type
Observational
2
Interventional
2
Sponsor
Cancer Type
Breast
2
Conditions
Breast Neoplasms
2
Interventions
Paclitaxel
20
Capecitabine
18
S 1 (combination)
17
Cisplatin
15
Oxaliplatin
11
Radiotherapy, Intensity-Modulated
9
apatinib
8
Epirubicin
8
Docetaxel
8
Carboplatin
8
Radiotherapy
7
Irinotecan
7
titanium silicide
6
sintilimab
6
pyrotinib
6
nimotuzumab
6
anlotinib
6
Drug Therapy
6
Albumin-Bound Paclitaxel
6
130-nm albumin-bound paclitaxel
6
nedaplatin
5
camrelizumab
5
Temozolomide
5
Etoposide
5
Bevacizumab
5
nabiximols
4
Vinorelbine
4
Trastuzumab
4
Radiation Dose Hypofractionation
4
Pemetrexed
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
UNKNOWN
×
Interventional
×
Fulvestrant
×
Clear all
NCT04033172
2019-07-25
Pyrotinib
ChineseAMS
Phase 2
Unknown
40 enrolled
NCT02646735
2017-01-02
FRIEND
ChineseAMS
Phase 2
Unknown
148 enrolled